Skip to main content

Table 2 Development of non-AIDS-defining cancers (NADCs) in patients with HIV infection (N = 1001)

From: Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study

Development of NADCs 61 (6.1%)
Development of gastrointestinal NADCs 31 (3.1%)
Median follow-up period (IQR), years 9.0 (4.8–13.2)
Stage at the time of NADC diagnosisa
 0 or I 14 (22.9%)
 II 17 (27.9%)
 III 9 (14.8%)
 IV 21 (34.4%)
Age at the time of NADC diagnosisa, years
 Median age (IQR) 57 (49–65)
 20–39 5 (8.2%)
 40–59 31 (50.8%)
 60–79 23 (37.7%)
 80–89 2 (3.3%)
 Antiretroviral therapy at the time of NADC diagnosisa 61 (100%)
  1. Note. aNumber and percentages were calculated among patients with NADCs (n = 61). Gastrointestinal cancer included cancers affecting the oral cavity, esophagus, stomach, colon, and anorectum.Abbreviations: IQR interquartile range, NADCs non-AIDS-defining cancers